| Financial Year |
March 31 2023 |
| Monetary Funds |
265,730,026.38 |
| Held-for-trading Financial Assets |
141,871,700.00 |
| Notes Receivable |
4,688,261.60 |
| Accounts Receivable |
219,504,870.41 |
| Advances to Suppliers |
29,005,084.89 |
| Other Receivables |
5,740,987.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
370,875,516.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,978,829.76 |
| Total Current Assets |
1,161,814,675.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,828,694.36 |
| Investment Properties |
-- |
| Fixed Assetes |
493,823,528.51 |
| Under-construction Projects |
7,020,598.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
226,943,679.54 |
| R&D expenses |
-- |
| Goodwill |
12,380,308.29 |
| Long-Term Deferred and Prepaid Expenses |
3,861,043.40 |
| Deferred Income Tax Assets |
14,443,140.89 |
| Other Non-Current Assets |
2,872.12 |
| Sub-Total of Non-Current Assets |
919,251,172.99 |
| Total Assets |
2,081,065,848.82 |
| Short-Term Loans |
134,609,703.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,340,638.00 |
| Accounts Payable |
104,068,530.75 |
| Accounts Received In Advance |
6,173,387.89 |
| Employee Compensation Payable |
32,385,941.46 |
| Taxes Payable |
9,808,727.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,972,789.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,844,415.85 |
| Other Current Liabilities |
310,356.96 |
| Sub-Total of Current Liabilities |
377,446,343.48 |
| Long-term Loans |
335,266,173.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
19,275,155.87 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,889,004.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
365,438,700.72 |
| Total Liabilities |
742,885,044.20 |
| Paid-In Capital(Or Share Stock) |
404,219,000.00 |
| Capital Surplus |
451,903,942.82 |
| Surplus Reserve |
68,189,083.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
373,235,655.55 |
| Minority Stockholder's Interest |
13,121,189.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,325,059,615.12 |
| Owner's Equity（Stockholder's Equity） |
1,338,180,804.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,081,065,848.82 |
